Riyadh is preparing to host CPHI Middle East 2026 from 14 to 16 December 2026 at the Riyadh Exhibition and Convention Center in Malham, bringing pharmaceutical industry leaders, manufacturers, suppliers, innovators and specialists from around the world together on an international platform aimed at strengthening partnerships and exploring the latest products, solutions and developments shaping the future of the pharmaceutical sector.
The 2026 edition is larger than before. The 2024 edition drew more than 30,000 visitors from more than 100 countries, and official projections for the upcoming edition point to around 60,000 visitors, more than 1,000 exhibiting companies and brands, and participation from more than 100 countries.
A Global Platform for the Pharmaceutical Supply Chain
CPHI Middle East is a meeting point for every part of the pharmaceutical industry, bringing manufacturers, suppliers, companies, specialists and decision-makers together in an environment that supports business relationships, market access and the exchange of knowledge on the latest regulatory changes and pharmaceutical innovations.
The exhibition covers every stage of the pharmaceutical supply chain, including active pharmaceutical ingredients (APIs), excipients, finished dosage forms, packaging and drug delivery systems, machinery and equipment, contract services, natural extracts and fine chemicals, as well as biomanufacturing, bioprocessing and drug discovery and development.
This range gives participating companies the chance to find new suppliers and partners, present their products and technologies, and reach business opportunities in the Saudi market and the markets of the Middle East and Africa.
Innovation and Modern Technology in Pharmaceuticals
The exhibition places pharmaceutical innovation and modern technology among its main areas of focus, amid rapid change in research and development, manufacturing and supply chains.
The event is expected to be an important space for presenting the technologies and solutions that help pharmaceutical companies raise the efficiency of their operations and develop new products, along with developments in biomanufacturing and drug discovery and development.
Rapid progress in artificial intelligence and digital transformation is also opening new horizons for the pharmaceutical industry, from data analysis and faster research and discovery of drug compounds to improved manufacturing, quality and supply chain management, making digital technology an increasingly important element in the sector's future.
BIO Middle East Alongside CPHI
The 2026 edition gains added importance with BIO Middle East 2026 taking place in Riyadh over the same period, adding a specialized dimension in biotechnology and life sciences and strengthening connections between the pharmaceutical industry, biotechnology companies, investors and researchers.
This integration opens the way to exploring advanced fields such as biomanufacturing, cell and gene therapy, mRNA technology and modern vaccines, along with partnership, licensing and investment opportunities.
